Allegria Therapeutics

Allegria Therapeutics is a Swiss biotech company focused on developing novel therapeutic approaches for mast cell-mediated diseases. The company aims to redefine treatment for allergies and inflammatory diseases by selectively modulating mast cells. Its research collaborates with leading experts in mast cell biology and drug discovery.

Buy Funded Startups lists

Funding Round: Seed

Funding Amount: $3.5M

Date: 06-May-2024

Investors: Forty51 Ventures

Markets: Biotech, Pharmaceuticals, Mast Cell-Targeted Therapeutics, Allergy, and Inflammatory Disease

HQ: Basel, Basel-Stadt, Switzerland

Founded: 2023

Website: http://www.allegriatx.com

LinkedIn: https://www.linkedin.com/company/allegriatx/

Twitter:

Instagram: